In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...

British pharmaceutical company GSK has agreed to pay $2.3 billion to settle lawsuits alleging that its heart burn medication Zantac caused cancer. GSK has settled 80,000 Zantac lawsuit. Watch to know ...

As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...

Highlights:,GSK PLC has reached a $2.2 billion settlement that addresses 93% of the ongoing litigation related to its ...

Highlights:,GSK PLC has reached a settlement agreement of up to $2.2 billion to resolve approximately 80,000 lawsuits related ...

Alembic has a cumulative total of 216 ANDA approvals (188 final approvals and 28 tentative approvals) from USFDA.

Sustainalytics’ controversies research identifies companies involved in incidents and events that may negatively affect stakeholders, the environment or the company’s operations. Controversies are ...

When she was asked to front GSK Thrive@50+, a campaign that encourages women to spread awareness of and learn about their risk for potential health challenges like shingles, her answer was clear.

GSK PLC GSK shares inched up 0.33% to £15.22 Tuesday, on what proved to be an all-around great trading session for the stock ...

GSK just settled another 2 (two) lawsuits in the UNITED STATES. And guess what folks AGAIN they admit ZERO LIABILITY. Now they have 76,998 lawsuits to go. Horrible MS EMMA allows the jury system ...